NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.33%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.02B
AUM Growth
+$21.8M
(+2.2%)
Cap. Flow
-$93.3M
Cap. Flow
% of AUM
-9.14%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
137
New
19
Increased
22
Reduced
37
Closed
18
Top Buys
| 1 |
Peloton Interactive
PTON
|
+$13.1M |
| 2 |
Tourmaline Bio
TRML
|
+$6.64M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$6.6M |
| 4 |
eHealth
EHTH
|
+$5.55M |
| 5 |
CONN
Conn's Inc.
CONN
|
+$4.73M |
Top Sells
| 1 |
Establishment Labs
ESTA
|
+$25.7M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$19.7M |
| 3 |
Soleno Therapeutics
SLNO
|
+$19.1M |
| 4 |
Luxfer Holdings
LXFR
|
+$11.7M |
| 5 |
Cytokinetics
CYTK
|
+$9.19M |
Sector Composition
| 1 | Healthcare | 63.23% |
| 2 | Consumer Discretionary | 13.84% |
| 3 | Financials | 7.05% |
| 4 | Communication Services | 5.88% |
| 5 | Technology | 3.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
RH
RH
$4.27B
| – | – |
0
| – | – |
|
127
Cartesian Therapeutics
RNAC
$259M
| – | – |
-74,474
| Closed | -$1.54M |
|
128
ARS Pharmaceuticals
SPRY
$1B
| – | – |
-1,596,504
| Closed | -$8.75M |
|
129
Sensus Healthcare
SRTS
$53.3M
| – | – |
-176,750
| Closed | -$417K |
|
130
Zoom
ZM
$25.4B
| – | – |
0
| – | – |
|
|
LENZ
131
LENZ Therapeutics
LENZ
$1.16B
| – | – |
-117,282
| Closed | -$2.15M |
|
|
SCTL
132
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| – | – |
-1,214,706
| Closed | -$426K |
|
|
AYX
133
DELISTED
Alteryx, Inc.
AYX
| – | – |
-99,093
| Closed | -$4.67M |
|
|
SRT
134
DELISTED
Startek Inc.
SRT
| – | – |
-786,913
| Closed | -$3.47M |
|
|
EAR
135
DELISTED
Eargo, Inc. Common Stock
EAR
| – | – |
-495,582
| Closed | -$1.28M |
|